The DCNN works to advance our understanding of neurodegenerative disease, with the expectation that such advances will offer opportunities for leveraging acquired mechanistic knowledge into substantive opportunities for therapy development.
Andrew West, PhD Director, Duke Center for Neurodegeneration and Neurotherapeutics Professor of Pharmacology and Cancer Biology Read Dr. West’s “Profiles in Brain Sciences” interview here. |
|
Recent Comments